SMI
11.871,32
PKT
-0,20
PKT
±0,00
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Nestlé Underperform | RBC Capital Markets | |
| 25.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 25.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.23 | Nestlé Hold | Jefferies & Company Inc. | |
| 25.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 24.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.23 | Givaudan Sell | UBS AG | |
| 21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 18.04.23 | Givaudan Underperform | Bernstein Research | |
| 17.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Givaudan Sell | UBS AG | |
| 17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 14.04.23 | Givaudan Hold | Deutsche Bank AG | |
| 14.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Richemont Buy | UBS AG | |
| 13.04.23 | Swiss Re Equal Weight | Barclays Capital | |
| 13.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Givaudan Sell | UBS AG | |
| 13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.